The Application Notebook
Agilent Application Note
This application demonstrates that stringent sensitivity requirements for the detection of potentially harmful primary aromatic amines can be fulfilled when using an Agilent 1290 Infinity LC system equipped with the 1290 large volume injection kit.
Primary aromatic amines (PAAs) can originate from printing azodyes and azo-pigments. PAAs are potentially harmful and suspected to cause cancer; they have to be detected and determined.
Regulation (EC) 10/2011 sets a limit of 10 ppb for the sum of the released PAAs from plastic food contactmaterials. In the field of paper and board for food contact a similar limit is mentioned within BfR recommendation XXXVI. Moreover, the upcoming German regulation for printing inks used for food contact materials (Druckfarben V) negates the already introduced limit of 10 ppb for the sum of the released PAAs to all materials. Recently, problems have been reported within industry and enforcement authorities regarding the release of carcinogenic PAAs from heavily printed paper bags and napkins.
Figure 1: Primary aromatic amines at 100 ng/mL: 1) Aniline: 3.314 min, 2) o-Anisidine: 4.882 min, 3) o-Toluidine: 5.159 min, 4) 2-Methyl-5-nitroanilin: 6.488 min, 5) 2,4-dimethylanilin: 7.908 min and 6) 2,4-dichloranilin: 11.373 min.
Since the legal limits apply to the sum of all PAAs, these compounds have to be detected down to a level of at least 1 ppb (1 ng/mL) for an individual PAA.
To meet these requirements, two modifications were made to the standard configuration of the Agilent 1290 Infinity LC System. A 60-mm Max-Light high sensitivity flow cell was used with the 1290 Infinity Diode Array Detector. A 40-µL loop including the 1290 large volume injection kit to inject volumes up to 120 µL was used with the 1290 Infinity Autosampler.
The method that was finally applied was developed by using a mixture of six primary aromatic amines at 100 ng/mL: 1) aniline, 2) o-anisidine, 3) o-toluidine, 4) 2-methyl-5-nitroanilin, 5) 2, 4-dimethylanilin and 6) 2, 4-dichloranilin (Figure 1).
The method starts with an enrichment step for the first minute followed by a steep increase to the starting conditions at 20% methanol. The gradient separation was done in the following 13 min up to 70% methanol on an Agilent ZORBAX Eclipse Plus C18, RRHT, 3.0 × 100 mm, 1.8 µm column.
With the final method, a calibration was done for all PAAs from 100 ng/mL down to a level of 2 ng/mL (2 ppb). All linearity correlation coefficients were above 0.99983. The concentration level at 2 ng/mL was defined as the limit of quantification (LOQ signaltonoise ratio around 10). The limit of detection (LOD) was 0.5 ng/mL (signaltonoise ratio around 3).
A statistical evaluation was done on the 10 ng/mL level. The relative standard deviation (RSD) of the retention times was between 0.039% and 0.057%, the area RSDs were between 0.5% and 2.7%. Relative standard deviation of the compound response factors were between 0.004 and 0.017%.
To test the method, a blank matrix sample produced from a heavily coloured napkin was spiked with the six PAAs at various concentrations. All six PAAs could be well separated from the matrix compounds and identified and quantified with the developed method and calibration.
This application shows that the Agilent 1290 Infinity LC system can detect low amounts of primary aromatic amines by using the 60mm Max-Light high sensitivity cell in the diode array detector, and the large volume injection kit in the autosampler.
Agilent Technologies Inc.
5301 Stevens Creek Blvd., Santa Clara, California 95051, USA
tel. (800) 227 9770 (Directory) fax (866) 497 1134
Website: www.agilent.com
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.